Mechanisms of acute renal injury caused by SGLT-2 inhibitor in patients with diabetes mellitus
Sodium-glucose cotransporter-2 inhibitor is a type 2 diabetes(T2 DM) sugar-lowering agent.Numerous clinical trials have demonstrated that it could lower cardiovascular mortality in type 2 diabetics.As shown by growing evidence, use of SGLT-2 inhibitor was associated with the risk of acute kidney inj...
Saved in:
| Main Authors: | Gong Yan, He Qiao-yan, Yang Xiao-juan |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2021-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57903347&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in studies on renal effects and molecular mechanism of SGLT-2 inhibitors
by: XING Bei, et al.
Published: (2020-01-01) -
The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis
by: Chung-Shu Lee, et al.
Published: (2025-05-01) -
SGLT2 inhibitor administration to two patients with diabetes mellitus with ascites due to cirrhosis
by: Koji Nagayama, et al.
Published: (2025-07-01) -
Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy
by: Kong Ling-li, et al.
Published: (2021-01-01) -
Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched Study
by: Jeong-Hoon Lim, et al.
Published: (2024-08-01)